Aktana

Name: Aktana
Brand: Aktana
Rating: 4.2 (64 reviews)

Now part of PharmaForceIQ | Intelligent Customer Engagement for Life Sciences Teams

Est 2008|Valuation $150M|Raised $203.8M|14 Ref Customers

LinkedIn 19K|Web traffic 3K|FTEs 122|HQ San Francisco, California, US

MarketsReal-Time Guided Selling

01Competitive Landscape

Narrative competitive analysis

- Against Salesforce Life Sciences Cloud: Salesforce offers broad platform capabilities, published pricing for core offerings, and enterprise IT standardization. Some life sciences organizations evaluate specialized NBA/orchestration vendors for domain-specific requirements or to complement CRM capabilities. - Against Veeva: Veeva is entrenched in life sciences commercial execution. Aktana emphasizes integrations and an integration layer intended to reduce migration friction; assess whether integration patterns and operational templates demonstrably reduce migration and adoption risk. - Against in-house builds: Large firms with mature analytics teams may prefer custom NBA implementations. The vendor’s value proposition should be evaluated in terms of time-to-value, adoption support, and governance compared to internal alternatives.

	Aktana	Salesforce Life Sciences Cloud	Veeva (CRM/Vault CRM ecosystem)
Starting Price	Not publicly listed (enterprise quote-based); anecdotal invoice examples have been cited	Public list pricing for some offerings (listed on vendor site; billed annually)	Not publicly listed (enterprise quote-based)
Typical Fit	Organizations seeking a dedicated recommendation and orchestration solution that integrates with multiple CRM/data platforms	Organizations standardizing on Salesforce data models and platform services	Organizations committed to Veeva for life sciences CRM execution and governance
Key Strength	Focused recommendation and orchestration features for life sciences; integration layer designed for CRM transitions	Platform breadth, published pricing for core offerings, and extensive ecosystem	Widely adopted in life sciences with operational governance and partner ecosystem
Key Weakness	Pricing and TCO opacity in some deals; potential for significant services needs; replication risk for mature analytics organizations	Platform lock-in potential and integration/configuration requirements for NBA capabilities	Pricing and implementation opacity; reliance on partner ecosystem for specialized analytics

01Competitive Landscape

Narrative competitive analysis

Against Salesforce Life Sciences Cloud: Salesforce offers broad platform capabilities, published pricing for core offerings, and enterprise IT standardization. Some life sciences organizations evaluate specialized NBA/orchestration vendors for domain-specific requirements or to complement CRM capabilities.
Against Veeva: Veeva is entrenched in life sciences commercial execution. Aktana emphasizes integrations and an integration layer intended to reduce migration friction; assess whether integration patterns and operational templates demonstrably reduce migration and adoption risk.
Against in-house builds: Large firms with mature analytics teams may prefer custom NBA implementations. The vendor’s value proposition should be evaluated in terms of time-to-value, adoption support, and governance compared to internal alternatives.

	Aktana	Salesforce Life Sciences Cloud	Veeva (CRM/Vault CRM ecosystem)
Starting Price	Not publicly listed (enterprise quote-based); anecdotal invoice examples have been cited	Public list pricing for some offerings (listed on vendor site; billed annually)	Not publicly listed (enterprise quote-based)
Typical Fit	Organizations seeking a dedicated recommendation and orchestration solution that integrates with multiple CRM/data platforms	Organizations standardizing on Salesforce data models and platform services	Organizations committed to Veeva for life sciences CRM execution and governance
Key Strength	Focused recommendation and orchestration features for life sciences; integration layer designed for CRM transitions	Platform breadth, published pricing for core offerings, and extensive ecosystem	Widely adopted in life sciences with operational governance and partner ecosystem
Key Weakness	Pricing and TCO opacity in some deals; potential for significant services needs; replication risk for mature analytics organizations	Platform lock-in potential and integration/configuration requirements for NBA capabilities	Pricing and implementation opacity; reliance on partner ecosystem for specialized analytics